---
title: "Akso Health Group (AHG.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/AHG.US.md"
symbol: "AHG.US"
name: "Akso Health Group"
industry: "Health Care Distributors"
datetime: "2026-05-21T14:01:15.532Z"
locales:
  - [en](https://longbridge.com/en/quote/AHG.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AHG.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AHG.US.md)
---

# Akso Health Group (AHG.US)

## Company Overview

Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People’s Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as technological promotion services and import and export.

| Item | Detail |
|------|--------|
| Industry | Health Care Distributors |
| Exchange | US Market |
| Website | [www.ahgtop.com](https://www.ahgtop.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:18.000Z

**Overall: C (0.52)**

**Industry**: Health Care Distributors

| Metric | Value |
|--------|-------|
| Industry Ranking | 6 / 16 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 75.55% |  |
| Net Profit YoY | -1959.37% |  |
| P/B Ratio | 4.45 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 882977881.60 |  |
| Revenue | 14842253.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -68.03% | E |
| Profit Margin | -914.06% | E |
| Gross Margin | 8.90% | E |
| Revenue YoY | 75.55% | A |
| Net Profit YoY | -1959.37% | E |
| Total Assets YoY | -0.43% | D |
| Net Assets YoY | -1.17% | D |
| Cash Flow Margin | -5.35% | D |
| OCF YoY | 75.55% | A |
| Turnover | 0.07 | E |
| Gearing Ratio | 6.48% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Akso Health Group",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "75.55%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-1959.37%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "4.45",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "882977881.60",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "14842253.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-68.03%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-914.06%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "8.90%",
          "rating": "E"
        },
        {
          "name": "Revenue YoY",
          "value": "75.55%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-1959.37%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-0.43%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-1.17%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-5.35%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "75.55%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.07",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "6.48%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -6.51 | 12/16 | - | - | - |
| PB | 4.45 | 7/16 | 5.10 | 4.18 | 3.18 |
| PS (TTM) | 59.49 | 12/16 | 75.43 | 61.24 | 52.98 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Henry Schein (HSIC.US) | B | C | A | D | B | B |
| 02 | ZeroStack (ZSTK.US) | E | B | A | A | B | B |
| 03 | McKesson (MCK.US) | E | B | A | E | B | C |
| 04 | Cencora (COR.US) | B | B | A | E | C | C |
| 05 | Cardinal Health (CAH.US) | E | C | A | E | B | C |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/AHG.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/AHG.US/norm.md)
- [Related News](https://longbridge.com/en/quote/AHG.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/AHG.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**